(Q46227941)

20 December 2017

title

Advanced mast cell disease: an Italian Hematological Multicenter experience (English)

1 reference

20 December 2017

0 references

0 references

23

1 reference

20 December 2017

Pellegrino Musto

24

1 reference

20 December 2017

Michela Rondoni

object named as

Michela Rondoni

4

0 references

Luana Fianchi

object named as

Luana Fianchi

18

0 references

Giovanni Martinelli

22

object named as

Giovanni Martinelli

1 reference

20 December 2017

1

Livio Pagano

1 reference

20 December 2017

author name string

Caterina Giovanna Valentini

2

1 reference

20 December 2017

Morena Caira

3

1 reference

20 December 2017

Maria Teresa Van Lint

5

1 reference

20 December 2017

Anna Candoni

6

1 reference

20 December 2017

Bernardino Allione

7

1 reference

20 December 2017

Chiara Cattaneo

8

1 reference

20 December 2017

Laura Marbello

9

1 reference

20 December 2017

Cecilia Caramatti

10

1 reference

20 December 2017

Enrico Maria Pogliani

11

1 reference

20 December 2017

Emilio Iannitto

12

1 reference

20 December 2017

Fiorina Giona

13

1 reference

20 December 2017

Felicetto Ferrara

14

1 reference

20 December 2017

Rosangela Invernizzi

15

1 reference

20 December 2017

Rosa Fanci

16

1 reference

20 December 2017

Monia Lunghi

17

1 reference

20 December 2017

Grazia Sanpaolo

19

1 reference

20 December 2017

Pietro Maria Stefani

20

1 reference

20 December 2017

Alessandro Pulsoni

21

1 reference

20 December 2017

publication date

26 November 2008

1 reference

20 December 2017

International Journal of Hematology

published in

1 reference

20 December 2017

volume

88

1 reference

20 December 2017

issue

5

1 reference

20 December 2017

page(s)

483-488

1 reference

20 December 2017

https://scigraph.springernature.com/pub.10.1007/s12185-008-0166-4

exact match

0 references

cites work

Interest of interferon alpha in systemic mastocytosis. The French experience and review of the literature

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12185-008-0166-4

Treatment of systemic mast cell disease: beyond interferon

21 January 2018

1 reference

12 December 2020

Imatinib for systemic mast-cell disease

1 reference

12 December 2020

Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms

1 reference

12 December 2020

Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings.

1 reference

12 December 2020

Mast cell proliferative disorders: current view on variants recognized by the World Health Organization

1 reference

12 December 2020

Imatinib mesylate (STI571) for myeloid malignancies other than CML.

1 reference

12 December 2020

Management of patients with systemic mastocytosis: review of M. D. Anderson Cancer Center experience

1 reference

12 December 2020

Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: report of five cases and review of the literature.

1 reference

12 December 2020

How we diagnose and treat WHO-defined systemic mastocytosis in adults

1 reference

12 December 2020

Imatinib mesylate in the treatment of systemic mastocytosis: a phase II trial

1 reference

12 December 2020

Persistence of systemic mastocytosis after allogeneic bone marrow transplantation in spite of complete remission of the associated myelodysplastic syndrome

1 reference

12 December 2020

Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria

1 reference

12 December 2020

Effects of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, on human mast cells bearing wild-type or mutated codon 816 c-kit

1 reference

12 December 2020

Novel approaches in the treatment of systemic mastocytosis

1 reference

12 December 2020

Diagnostic criteria and classification of mastocytosis: a consensus proposal

1 reference

12 December 2020

Cladribine therapy for systemic mastocytosis.

1 reference

12 December 2020

Systemic mastocytosis: bone marrow pathology, classification, and current therapies

1 reference

12 December 2020

Treatment of systemic mast cell disease with 2-chlorodeoxyadenosine

1 reference

12 December 2020

Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit

1 reference

12 December 2020

Evidence for a graft-versus-mast-cell effect after allogeneic bone marrow transplantation

1 reference

12 December 2020

Diagnosis and treatment of systemic mastocytosis: state of the art.

1 reference

12 December 2020

Dasatinib therapy for systemic mastocytosis: four cases

1 reference

12 December 2020

PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects

1 reference

12 December 2020

Dasatinib (BMS-354825) inhibits KITD816V, an imatinib-resistant activating mutation that triggers neoplastic growth in most patients with systemic mastocytosis

1 reference

12 December 2020

Treatment of systemic mast-cell disease with cladribine

1 reference

12 December 2020

Treatment of adult systemic mastocytosis with interferon-alpha: results of a multicentre phase II trial on 20 patients

1 reference

12 December 2020

A pilot study of nonmyeloablative allogeneic hematopoietic stem cell transplant for advanced systemic mastocytosis

1 reference

12 December 2020

Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosis

1 reference

12 December 2020

Evaluation of mast cells in myeloproliferative disorders and myelodysplastic syndromes

1 reference

12 December 2020

10.1007/S12185-008-0166-4

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017